HHLR Advisors’s Legend Biotech LEGN Stock Holding History

HHLR Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$173M	Hold	5,984,550	–	–	20.77%	1
2026 Q1	$108M	Hold	5,984,550	–	–	6.47%	5
2025 Q4	$130M	Hold	5,984,550	–	–	4.19%	5
2025 Q3	$195M	Hold	5,984,550	–	–	4.77%	7
2025 Q2	$212M	Hold	5,984,550	–	–	6.84%	6
2025 Q1	$203M	Hold	5,984,550	–	–	5.74%	7
2024 Q4	$195M	Sell	5,984,550 -651,946	-10%	-$27M	6.74%	7
2024 Q3	$323M	Hold	6,636,496	–	–	7.1%	4
2024 Q2	$294M	Buy	6,636,496 +651,946	+11%	+$30.1M	7.25%	5
2024 Q1	$336M	Hold	5,984,550	–	–	7.29%	4
2023 Q4	$360M	Sell	5,984,550 -451,983	-7%	-$28.6M	7.26%	4
2023 Q3	$432M	Hold	6,436,533	–	–	9.65%	4
2023 Q2	$444M	Buy	6,436,533 +1,306,166	+25%	+$85.3M	9.46%	4
2023 Q1	$247M	Sell	5,130,367 -6,250	-0.1%	-$306K	4.39%	8
2022 Q4	$256M	Hold	5,136,617	–	–	5.41%	6
2022 Q3	$210M	Buy	5,136,617 +700,000	+16%	+$32.9M	5.51%	5
2022 Q2	$244M	Sell	4,436,617 -2,500,000	-36%	-$106M	5.23%	7
2022 Q1	$252M	Sell	6,936,617 -4,868,308	-41%	-$192M	5.26%	5
2021 Q4	$550M	Buy	11,804,925 +750,000	+7%	+$38M	8.5%	3
2021 Q3	$559M	Buy	11,054,925 +10,404,925	+1,601%	+$433M	7.31%	2
2021 Q2	$26.7M	Hold	650,000	–	–	0.27%	47
2021 Q1	$18.9M	Hold	650,000	–	–	0.19%	50
2020 Q4	$18.3M	Hold	650,000	–	–	0.15%	60
2020 Q3	$20.1M	Hold	650,000	–	–	0.15%	47
2020 Q2	$27.7M	Buy	+650,000	New	+$25.4M	0.25%	36

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

HHLR Advisors's LEGN Position: Q2 2026 in Review

HHLR Advisors held its Legend Biotech (LEGN) position steady in Q2 2026 at 5,984,550 shares worth $173M. The position accounts for 20.77% of the portfolio, ranked #1.

HHLR Advisors first reported a position in LEGN in Q2 2020 and has held it in 25 quarters since. The position peaked at $559M in Q3 2021. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

HHLR Advisors held 5,984,550 shares of Legend Biotech worth $173M as of Q2 2026.
HHLR Advisors left its Legend Biotech share count unchanged in Q2 2026.
Legend Biotech made up 20.77% of HHLR Advisors's portfolio in Q2 2026, its #1 holding.
HHLR Advisors first reported a position in Legend Biotech in Q2 2020 and has held it in 25 quarters since.
HHLR Advisors's Legend Biotech position peaked at $559M in Q3 2021.
218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on HHLR Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.